Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Characterization of Novel Splice Variants of LGR7 and LGR8 Reveals That Receptor Signaling Is Mediated by Their Unique Low Density Lipoprotein Class A Modules*
Daniel J. Scott1,
Sharon Layfield,
Yan Yan¶,
Satoko Sudo||,
Aaron J. W. Hsueh||,
Geoffrey W. Tregear, , and
Ross A. D. Bathgate2
Howard Florey Institute and Department of Biochemistry and Molecular Biology, University of Melbourne, Victoria 3010, Australia, the ||Division of Reproductive Biology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, California 94305-5317, and the ¶National Laboratory of Protein Engineering and Plant Genetic Engineering, College of Life Sciences, Peking University, Beijing 100871, China
Abstract:
The relaxin and insulin-like peptide 3 receptors, LGR7 and LGR8,respectively, are unique members of the leucine-rich repeat-containingG-protein-coupled receptor (LGR) family, because they possessan N-terminal motif with homology to the low density lipoproteinclass A (LDLa) modules. By characterizing several LGR7 and LGR8splice variants, we have revealed that the LDLa module directsligand-activated cAMP signaling. The LGR8-short variant encodesan LGR8 receptor lacking the LDLa module, whereas LGR7-truncate,LGR7-truncate-2, and LGR7-truncate-3 all encode truncated secretedproteins retaining the LGR7 LDLa module. LGR8-short and an engineeredLGR7 variant missing its LDLa module, LGR7-short, bound to theirrespective ligands with high affinity but lost their abilityto signal via stimulation of intracellular cAMP accumulation.Conversely, secreted LGR7-truncate protein with the LDLa modulewas able to block relaxin-induced LGR7 cAMP signaling and didso without compromising the ability of LGR7 to bind to relaxinor be expressed on the cell membrane. Although the LDLa moduleof LGR7 was N-glycosylated at position Asn-14, an LGR7 N14Qmutant retained relaxin binding affinity and cAMP signaling,implying that glycosylation is not essential for optimal LDLafunction. Using real-time PCR, the expression of mouse LGR7-truncatewas detected to be high in, and specific to, the uterus of pregnantmice. The differential expression and evolutionary conservationof LGR7-truncate further suggests that it may also play an importantrole in vivo. This study highlights the essential role of theLDLa module in LGR7 and LGR8 function and introduces a novelmodel of GPCR regulation.
Received for publication March 23, 2006.
Revision received July 24, 2006.
* This work was supported in part by an Australian National Healthand Medical Research Council Project grant (#30012 to R. A.D. B. and G. W. T.). The costs of publication of this articlewere defrayed in part by the payment of page charges. This articlemust therefore be hereby marked "advertisement" in accordancewith 18 U.S.C. Section 1734 solely to indicate this fact.
1 Recipient of an Australian Postgraduate Award.
2 To whom correspondence should be addressed. Tel.: 61-3-8344-5648; Fax: 61-3-9347-0446; E-mail: r.bathgate{at}hfi.unimelb.edu.au.
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
L. Bryan Ray (21 November 2006) Sci. STKE2006 (362), tw396.
[DOI: 10.1126/stke.3622006tw396] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Relaxin Family Peptides and Their Receptors.
R. A. D. Bathgate, M. L. Halls, E. T. van der Westhuizen, G. E. Callander, M. Kocan, and R. J. Summers (2013)
Physiol Rev
93, 405-480
|Abstract »|Full Text »|PDF »
Identification of Small-Molecule Agonists of Human Relaxin Family Receptor 1 (RXFP1) by Using a Homogenous Cell-Based cAMP Assay.
C. Z. Chen, N. Southall, J. Xiao, J. J. Marugan, M. Ferrer, X. Hu, R. E. Jones, S. Feng, I. U. Agoulnik, W. Zheng, et al. (2012)
J Biomol Screen
|Abstract »|Full Text »|PDF »
Identification of Key Residues Essential for the Structural Fold and Receptor Selectivity within the A-chain of Human Gene-2 (H2) Relaxin.
L. J. Chan, K. J. Rosengren, S. L. Layfield, R. A. D. Bathgate, F. Separovic, C. S. Samuel, M. A. Hossain, and J. D. Wade (2012)
J. Biol. Chem.
287, 41152-41164
|Abstract »|Full Text »|PDF »
The Different Ligand-Binding Modes of Relaxin Family Peptide Receptors RXFP1 and RXFP2.
D. J. Scott, K. J. Rosengren, and R. A. D. Bathgate (2012)
Mol. Endocrinol.
26, 1896-1906
|Abstract »|Full Text »|PDF »
Relaxin mediates uterine artery compliance during pregnancy and increases uterine blood flow.
L. A. Vodstrcil, M. Tare, J. Novak, N. Dragomir, R. J. Ramirez, M. E. Wlodek, K. P. Conrad, and L. J. Parry (2012)
FASEB J
26, 4035-4044
|Abstract »|Full Text »|PDF »
The Minimal Active Structure of Human Relaxin-2.
M. A. Hossain, K. J. Rosengren, C. S. Samuel, F. Shabanpoor, L. J. Chan, R. A. D. Bathgate, and J. D. Wade (2011)
J. Biol. Chem.
286, 37555-37565
|Abstract »|Full Text »|PDF »
Relaxin family peptides in the male reproductive system--a critical appraisal.
R. Ivell, M. Kotula-Balak, D. Glynn, K. Heng, and R. Anand-Ivell (2011)
Mol. Hum. Reprod.
17, 71-84
|Abstract »|Full Text »|PDF »
Evidence for expression of relaxin hormone-receptor system in the boar testis.
S. Kato, Siqin, I. Minagawa, T. Aoshima, D. Sagata, H. Konishi, K. Yogo, T. Kawarasaki, H. Sasada, H. Tomogane, et al. (2010)
J. Endocrinol.
207, 135-149
|Abstract »|Full Text »|PDF »
Decreased Expression of the Rat Myometrial Relaxin Receptor (RXFP1) in Late Pregnancy Is Partially Mediated by the Presence of the Conceptus.
L. A. Vodstrcil, O. Shynlova, J. W. Verlander, M. E. Wlodek, and L. J. Parry (2010)
Biol Reprod
83, 818-824
|Abstract »|Full Text »|PDF »
Biology of insulin-like factor 3 in human reproduction.
Prolonged RXFP1 and RXFP2 signaling can be explained by poor internalization and a lack of {beta}-arrestin recruitment.
G. E. Callander, W. G. Thomas, and R. A. D. Bathgate (2009)
Am J Physiol Cell Physiol
296, C1058-C1066
|Abstract »|Full Text »|PDF »
The A-chain of Human Relaxin Family Peptides Has Distinct Roles in the Binding and Activation of the Different Relaxin Family Peptide Receptors.
M. A. Hossain, K. J. Rosengren, L. M. Haugaard-Jonsson, S. Zhang, S. Layfield, T. Ferraro, N. L. Daly, G. W. Tregear, J. D. Wade, and R. A. D. Bathgate (2008)
J. Biol. Chem.
283, 17287-17297
|Abstract »|Full Text »|PDF »
Cloning, Expression, and Functional Characterization of Relaxin Receptor (Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 7) Splice Variants from Human Fetal Membranes.
A. Kern, D. Hubbard, A. Amano, and G. D. Bryant-Greenwood (2008)
Endocrinology
149, 1277-1294
|Abstract »|Full Text »|PDF »
Defining the LGR8 Residues Involved in Binding Insulin-Like Peptide 3.
D. J. Scott, T. N. Wilkinson, S. Zhang, T. Ferraro, J. D. Wade, G. W. Tregear, and R. A. D. Bathgate (2007)
Mol. Endocrinol.
21, 1699-1712
|Abstract »|Full Text »|PDF »
The Low-Density Lipoprotein Class A Module of the Relaxin Receptor (Leucine-Rich Repeat Containing G-Protein Coupled Receptor 7): Its Role in Signaling and Trafficking to the Cell Membrane.
A. Kern, A. I. Agoulnik, and G. D. Bryant-Greenwood (2007)
Endocrinology
148, 1181-1194
|Abstract »|Full Text »|PDF »
The NMR Solution Structure of the Relaxin (RXFP1) Receptor Lipoprotein Receptor Class A Module and Identification of Key Residues in the N-terminal Region of the Module That Mediate Receptor Activation.
E. J. Hopkins, S. Layfield, T. Ferraro, R. A. D. Bathgate, and P. R. Gooley (2007)
J. Biol. Chem.
282, 4172-4184
|Abstract »|Full Text »|PDF »
Comparison of Signaling Pathways Activated by the Relaxin Family Peptide Receptors, RXFP1 and RXFP2, Using Reporter Genes.
M. L. Halls, R. A. D. Bathgate, and R. J. Summers (2007)
J. Pharmacol. Exp. Ther.
320, 281-290
|Abstract »|Full Text »|PDF »